RH (NYSE:RH) reported upbeat second-quarter earnings.
RH reported quarterly earnings of $3.93 per share, which beat the analyst consensus estimate of $2.56, a 51.36% decrease over earnings of $8.08 per share from last year. The company reported quarterly sales of $800.48 million, which beat the analyst consensus estimate of $784.90 million, a 19.28% decrease over sales of $991.62 million in the same period last year.
RH also sees third-quarter revenue between $740 million and $760 million, versus the $772.87 million estimate, and fourth-quarter revenue between $760 million and $800 million versus the $774.71 million estimate.
RH shares fell 12% to trade at $324.44 on Friday.
These analysts made changes to their price targets on RH following earnings announcement.
Wells Fargo raised the price target on RH from $300 to $375. Wells Fargo analyst Zachary Fadem maintained an Overweight rating.
UBS cut the price target on RH from $350 to $340. UBS analyst Michael Lasser maintained a Neutral rating.
Citigroup lowered the price target on RH from $460 to $440. Citigroup analyst Steven Zaccone maintained a Buy rating.
Check This Out: Top 5 Health Care Stocks That May Explode In Q3
